Results 31 to 40 of about 181,836 (188)
Thymectomy for myasthenia gravis: A pathological analysis
Indian Journal of Pathology and Microbiology, 2022 Background: Myasthenia gravis (MG) is a prototypic T-cell-dependent antibody-mediated autoimmune disease that leads to ocular or generalized muscular weakness.
Shweta Bansod +3 more
doaj +1 more source
Tolosa-Hunt syndrome with general myasthenia gravis involvement [PDF]
Journal of Integrative Neuroscience, 2020 Tolosa-Hunt syndrome is an uncommon disease that exhibits unilateral periorbital pain or headache, accompanied by cranial nerve palsies. Myasthenia gravis is an acquired immune system disease involving the neuromuscular junction.
Lu Li, Zhe Wang, Ming-Ou Lu
doaj +1 more source
A conceptual framework for evaluating impairments in myasthenia gravis. [PDF]
PLoS ONE, 2014 BACKGROUND:Myasthenia gravis is characterized by weakness and fatigability of different muscle groups, including ocular, bulbar and the limbs. Therefore, a measure of disease severity at the impairment level in myasthenia needs to reflect all the ...
Carolina Barnett +4 more
doaj +1 more source
Ocular myasthenia gravis: A case series
TNOA Journal of Ophthalmic Science and Research, 2020 Aim: To report the clinical profile of patients with myasthenia gravis (MG) at a tertiary eye care center in Tamil Nadu. Material and Methods: This is a retrospective case series of patients in a single center between February 2019 and March 2020. Result:
Sandra C Ganesh, Amrutha Sindhu, Jogitha
doaj +1 more source
Inebilizumab in AQP4‐Seropositive NMOSD: One‐Year Follow‐Up From a Multicenter, Real‐World Study
Annals of Clinical and Translational Neurology, EarlyView.ABSTRACT Objective Real‐world evidence on inebilizumab among neuromyelitis optica spectrum disorder (NMOSD) patients is lacking. This study assessed inebilizumab among Chinese patients with aquaporin 4 autoantibody (AQP4‐IgG)‐seropositive NMOSD in a real‐world setting.
Mengcui Gui +10 more
wiley +1 more source
, 2018 Pure ocular myasthenia was always described as a separate entity in historical publications. More than 50% of patients develop generalized symptoms in the course of the disease.
Sophie Schötz +2 more
core +1 more source
Trauma-Induced Double-Seronegative Ocular Myasthenia Gravis: A Case Report
Journal of Rawalpindi Medical CollegeWe present here a 12-year-old child who presented with complaints of blurring of vision and drooping of the left upper eyelid for the past 4 years, which started 1 month after he encountered blunt trauma to the left-sided orbital region.
Mohammad Ali Khalid +5 more
doaj +1 more source
Head &Neck, EarlyView.ABSTRACT Background Supportive care needs of patients receiving immune checkpoint inhibitors (ICIs) for head and neck squamous cell carcinoma (HNSCC) are ill‐defined. Hence, known treatment‐related adverse events (TRAEs) and health‐related quality of life (HRQoL) associated with ICI treatment for HNSCC were examined to inform future supportive care ...
N. D. O'Donnell +11 more
wiley +1 more source
Journal of Applied Toxicology, EarlyView.ABSTRACT The N‐acylhydrazone scaffold is recognized as a privileged structure for the design of bioactive substances with increasing applications in medicinal chemistry research. Ensuring the safety of newly developed molecules is a critical step for both human health and environmental protection. Accordingly, this study aimed to evaluate the cytotoxic
Larissa Ribeiro Canuto Santos +4 more
wiley +1 more source
Medical and surgical treatment for ocular myasthenia
, 2012 Ocular myasthenia is a form of myasthenia gravis in which weakened eye muscles cause double vision or drooping eyelids. It accounts for approximately 50% of people with myasthenia gravis.
Kaminski, Henry J. +4 more
core +1 more source